@article{77b86e56eb2f4cda8f2a9316c6ed0a47,
title = "Social vulnerability indices: A pragmatic tool for COVID-19 policy and beyond",
author = "Mah, {Jasmine C.} and Andrew, {Melissa K.}",
note = "Funding Information: MKA and JCM are part of the Canadian Consortium on Neurodegeneration in Aging (CCNA) Team 14, which investigates how multi-morbidity, frailty and social context modify risk of dementia and patterns of disease expression. The CCNA receives funding from the Canadian Institutes of Health Research (CNA-137794) and partner organizations ( www.ccna-ccnv.ca ). Funding Information: JCM is an Internal Medicine resident with Nova Scotia Health and receives scholarships supporting her PhD research from the Department of Medicine at Dalhousie University, Dalhousie Medical Research Foundation, Dr. Patrick Madore Foundation, Alzheimer Society of Nova Scotia and the Pierre Elliott Trudeau Foundation. MKA reports grants from Sanofi, grants from GSK, grants from Pfizer, grants from Canadian Frailty Network, personal fees from Sanofi, personal fees from Pfizer, personal fees from Seqirus, grants from Merck, grants from Public Health Agency of Canada, grants from Canadian Institutes of Health Research, outside the submitted work. The funders had no input into any aspect of the research presented. Funding Information: MKA and JCM are part of the Canadian Consortium on Neurodegeneration in Aging (CCNA) Team 14, which investigates how multi-morbidity, frailty and social context modify risk of dementia and patterns of disease expression. The CCNA receives funding from the Canadian Institutes of Health Research (CNA-137794) and partner organizations (www.ccna-ccnv.ca).",
year = "2022",
month = mar,
doi = "10.1016/j.lanepe.2022.100333",
language = "English",
volume = "14",
journal = "The Lancet Regional Health - Europe",
issn = "2666-7762",
publisher = "Elsevier Limited",
}
